
X4 Pharmaceuticals, Inc
X4 Pharmaceuticals, Inc (XFOR)
WebsitePrice
Market cap
Next catalystExpected Q4 2026Mavorixafor — 4WARD; prior chronic-neutropenia study history · Enrollment completionCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
Approved / commercial
Approved
PreINDP1P2P3FilingApproved
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved